As stated in the open letter.

Aiying Company, or rather, Wu Zhou has already made relevant plans!

Although it seems that Aiying Group has received similar treatment to Juchang, and in terms of business proportion, it is actually about the same, and the proportion of foreign countries is not small!

However, the technological content of Aiying Group's products is still much lower than that of chrysanthemum factories!

However, after all, Aiying Group has only been established for a few years, and the chrysanthemum factory has been many years!

The second is the field involved in the chrysanthemum factory, and some subdivisions are much more than Wu Zhou's side!

Of course, if the scope is limited to those fields involved in Aiying Group, Wu Zhou's Aiying Company must be the world's leading level in terms of software!

In terms of hardware, even if it can't reach the global leadership, at least it can be the world's first-line!

Wu Zhou's tens of billions of dollars a year, coupled with the R&D and integration of AI technology, coupled with Wu Zhou's system help, and then to the convergence of talents from all walks of life!

And so on, and so on, many of the project results have not yet been fully released, if they are really all announced

Even in some fields, some old companies have a first-mover advantage and have obtained some necessary patent restrictions.

But Aiying Group is not without 'countermeasures!' ’

In general, Wu Zhou is not worried about being sanctioned at all!

On the contrary, it would even be glad to see this result!

This is the strongest country in the world, is it good to give his company a super advertisement for free?

The louder their momentum and the greater their movement, the higher the global popularity of Aiying Group!

This is also the reason why after the harsh sanctions were brought out over there, the global online media went crazy in an instant!

This propagation speed is faster than when it was in the original chrysanthemum factory, but I don't know how many times!

And then, as a company that is written in a small notebook and targeted by a world power, "can you still say that he has no technology?" How can a company without technology and without threats be written in a small book? ”

So. This wave, coupled with the period of the virus, Aiying Group's related products have formed a good reputation among consumers around the world!

Comprehensively

A subconscious has been preliminarily formed: "Aiying Group is a relatively powerful technology company in China!" Their technique is good! ”

With the rapid spread of news, Wu Zhou has also received calls from some leaders one after another!

The leader of his hometown province gave Wu Zhou a call!

To the effect that in the international community, they have also noticed whether there will be changes to the previously negotiated projects. This is a special case, and if there is a change, they can adjust some of the contract details!

And Wu Zhou's reply was, "Thank you for your concern, this matter doesn't matter!" The contract is executed as usual! ”

On the other hand, some departments in the capital are analyzing the reasons for the country.

Of course, the focus is also on the analysis of how big the 'threat coefficient' of Aiying Group is!

Huaxia is very big, so big that even though Aiying Group has a revenue of 100 billion, it still can't be managed, or it can't be fully noticed

Just like a sentence in the second volume of Mao Xuan!

"Whatever the enemy opposes, we will uphold; Whatever the enemy supports, we will oppose! ”

This time, Aiying Group has entered the field of vision of many leaders!

"I really didn't expect that this Xiao Wu would do so many things quietly!"

Wu Zhou's company has already entered the field of vision of some people in the upper class!

It's just that at the beginning, Wu Zhou was too young, and he was still doing things in the field of food supplies that had little technical content.

So the impression of the upper echelons of him is actually that he is a young entrepreneur who has a certain sense of family and country, and is very energetic, as for the product

Although the things are not bad, those that are eaten are actually not very influential! There are too many similar enterprises, even if the quality of Aiying Group's related products is the first in the industry, so what?

Later, Wu Zhou was involved in the field of biomedicine, invested a lot, and quickly developed the corresponding virus vaccine, which was an unexpected joy.

After all, there are many companies in Huaxia that can do the relevant inactivated biological vaccines! There's no such thing as a technical difficulty!

Therefore, Aiying Group still does not pay much attention, at most, Wu Zhou is willing to cooperate with the country greatly in terms of related interests, and even surrender all interests, which makes the upper echelons have a better impression of Wu Zhou!

Even a certain degree of preferential treatment is given!

I am also curious about what Wu Zhou can do in the future.

It's just that what I didn't expect was that this future would come so quickly!

After really investigating carefully, I found that some of them were dark under the lights.

The survey data from a few months ago and the survey data at hand now have changed dramatically!

For example, in the area of operating systems, Huaxia has developed so many independent operating systems, and many companies have made some achievements, but after so many years, Wu Zhou's Aiying has quietly and directly 'done the best in Huaxia'!

Another example is AI, Huaxia's AI has actually been developing, but it is more of an application side, that is, the industrial field, mainly to improve production efficiency!

It's just that what I didn't expect was that Aiying Group actually made a major breakthrough in generative AI and industrial AI, and directly entered the world's leading position.

According to their report, Aiying Group's AI technology has been applied to all aspects of their company's operations, such as R&D, design and planning, quality inspection, equipment predictive maintenance, production process control, operation and management optimization, product and service optimization, etc.!

The results are very good!

To take the most direct example, according to the revenue comparison!

For example, Nongfu Spring's revenue of 20 billion yuan last year had a total employee of less than 2W.

Moutai's revenue is less than 100 billion, and the total number of employees is more than 4w.

What about Aiying Group, with a revenue of 300 billion+, and a total number of employees of less than 2w.

The revenue created by a single employee is more than 6 times that of Moutai employees! It is more than 15 times that of Wahaha employees.

If you look at it from a different angle, you don't compare it from the retail industry.

Compared with the chrysanthemum factory, in 2020, the chrysanthemum factory will have a total revenue of about 900 billion yuan, and the total number of employees will be about 20w.

The average employee of Aiying Group generates more than three times the revenue of Ju Factory

However, there is still a slight gap between the world's first-class enterprises.

Take Apple, for example

In 2020, the total revenue will be about 270 billion US dollars, and the total number of employees will be about 6w!

The revenue generated by their individual employees is about 2 times that of Aiying Group!

But Apple is the number one in the world after all? And it is also necessary to consider another actual situation, Aiying Group's revenue is calculated in RMB, while Apple is in US dollars!

And with the passage of time, when China's national strength becomes stronger and stronger, the strength of the RMB will inevitably come!

Of course, don't think about that now, even if it's just the current situation!

According to the current development speed of Aiying Group, continue.

In 2021, which scientific and technological achievements will further develop and even gradually enter the stage of transformation?

What will happen to Aiying Group?

When the information goes further down.

There are more and more surprises! The expressions on everyone's faces are also getting richer and richer.

The smile on his face can't even be hidden!

Biomedicine!

Aiying Biotech has only been in the industry for a year.

However, last year's R&D investment has reached 15.7 billion yuan, much higher than the industry level in China. The total number of R&D teams has also soared to more than 3,900 people, of which more than 1,200 have doctoral degrees and more than 200 have overseas study or work experience!

In the past year, these people have screened more than 100,000 potential compounds through Aiying Group's AI technology, of which more than 3,000 have been verified as having drug activity, involving more than 100 drug targets.

During the same period, their company also published 297 high-level research papers in internationally renowned journals such as Cell, Nature, and The Lancet!

If you just look at this data and have no idea, it will be clear if you make a comparison.

In 2020, Huaxia published high-level international journal papers in the ranking of medical institutions, and the first place was Huaxi, with a total of 319 related papers published!

This is followed by Concord, with a total of 120 articles!

In other words, there are only 22 papers left, and the number of papers published by Aiying Biopharmaceutical Company can directly become the first in China!.

However, most biopharmaceutical companies do not publish academic papers frequently, and they focus more on drug development, clinical trials and commercialization.

Therefore, whether a pharmaceutical company's research results are strong or not is more reflected in patents, clinical data and drug marketing.

And in this regard!

Aiying Group's performance is also good, with a total of 251 applications in 2020 in the global biomedical industry invention patent ranking, as a comparison, the first place in China is Hengrui with 536 cases, the second place WuXi AppTec with 306 cases, the third place Chia Tai Tianqing with 287 cases, and the fourth place in China with Aiying Biopharma!

Of course, if you only look at these and then consider the establishment time of Aiying Biotech, you will feel that Wu Zhou's biomedical company is blindly brushing data!

After all, pharmaceutical R&D is not a 'fast-track' field!

And then you see.

Aiying Biopharma has also made major breakthroughs in the field of rare diseases and critical diseases, developing a total of 36 novel active substances, of which 16 have been granted priority review status by the National Medical Products Administration, 6 have been granted breakthrough therapy designation by the Food and Drug Administration, and 5 have been granted orphan drug designation by the European Medicines Agency.

Generally speaking, orphan drugs, breakthrough drugs for rare diseases and serious diseases, can apply for priority review and enjoy various preferential treatments, such as giving priority to review resources and shortening the review time limit, which is generally half or one-quarter of the regular review time limit. Priority is given to the arrangement of registered inspection and verification, and the procedures and requirements for inspection and verification are simplified. Priority will be given to administrative approvals, the issuance and publicity of administrative licenses will be accelerated, post-listing monitoring will be prioritized, and post-listing support and services will be provided.

If nothing else, perhaps in just three to five years, Aiying Biopharma will have a series of 'independent property rights, and the world's leading' drugs on the market!

But is that all?

Medical devices

Manufacturing upgrading, environmental protection, green energy, modern agriculture, pension.

The more I look, the more surprised I become, and the more I look at it, the more I am surprised!

I was pleasantly surprised that such talents must be 'protected' fiercely!!

(End of chapter)